Prostate Trials

Phase 3 Randomized, Double-Blind Study of Nivolumab of Placebo in Combination with Docetaxel, in Men with Metastatic Castration-Resistant Prostate Cancer
Awaiting activation.

Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer